3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features.

3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features.
复制标题

3Q26.2/MECOM重排的围环Inv(3):诊断挑战和临床病理学特征。

DOI:
10.3390/cancers15020458
复制
发表时间:
2023-01-11
期刊:
影响因子:
5.2
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

在这项研究中,17例急性髓性白血病(AML)患者被鉴定出在3p23 (n = 11)、3p25 (n = 3)、3p21 (n = 2)和3p13 (n = 1)和3q26.2 (3q)上存在环中心inv(3)畸变,导致MECOM重排(MECOM- r)。在17例患者中,有16例最初的核型分析忽略了这些中心周围基因突变,后来通过中期FISH分析发现了这些突变。与典型/旁中心性inv(3)(q21q26.2)的AML患者相比,我们的周中心性inv(3)s患者也表现出频繁的细胞减少,形态发育不良(特别是巨核细胞),−7/del(7q)和惨淡的结果(中位总生存期:14个月)。然而,该队列中的患者也表现出某些独特的特征:外周血中血小板减少(n = 15,88%)和单核细胞增多(n = 15,88%)的频率高,巨核细胞减少(n = 11,65%)。总之,通过染色体分析,中心周围内隐型通常是微妙的/隐匿的。髓系肿瘤显示- 7/del(7q)时,建议采用反射性FISH分析MECOM-R。3q26.2基因畸变导致的MECOM重排(MECOM- r)常与髓系肿瘤和不良预后相关。罕见的是,某些3q26.2/MECOM-R可能是微妙的/隐性的,因此被核型所忽略。我们鉴定了17例急性髓性白血病(AML)患者(男/女:13/4,中位年龄67岁,范围42 - 85岁),其中心周围inv(3)导致MECOM-R,断点分别为3p的3p23 (n = 11)、3p25 (n = 3)、3p21 (n = 2)和3p13 (n = 1),以及3q26.2。在17例患者中,有16例最初的核型分析忽略了这些中心周围基因突变,后来通过中期FISH分析发现了这些突变。与经典/旁中心型inv(3)(q21q26.2)患者相似,周中心型inv(3)患者表现出频繁的细胞减少、形态发育不良(尤其是巨核细胞)、- 7/del(7q)、频繁的NRAS (n = 6)、RUNX1 (n = 5)和FLT-3 (n = 4)突变,预后不佳(中位总生存期:14个月)。然而,中心周围型inv(3)患者更常发生伴有血小板减少(n = 15,88%)、外周血相对单核细胞增多(n = 15,88%)、巨核细胞减少(n = 11,65%)和SF3B1突变降低的AML。我们得出结论,AML伴周中心性inv(3)与经典/旁中心性inv(3)/GATA2::MECOM有一些相似之处,但也有一些独特的特征。通过染色体分析,心周内凹(3)通常是微妙的/隐匿的。髓系肿瘤显示- 7/del(7q)时,建议采用反射性FISH分析MECOM-R。
In this study, 17 acute myeloid leukemia (AML) patients were identified to pose a pericentric inv(3) aberration with breakpoints at 3p23 (n = 11), 3p25 (n = 3), 3p21 (n = 2) and 3p13 (n = 1) on 3p and 3q26.2 on 3q, leading to MECOM rearrangement (MECOM-R). These pericentric inv(3)s were overlooked by karyotyping initially in 16 of 17 cases and later detected by metaphase FISH analysis. Compared to AML patients with classic/paracentric inv(3)(q21q26.2), our patients with pericentric inv(3)s also exhibited frequent cytopenia, morphological dysplasia (especially megakaryocytes), −7/del(7q) and dismal outcomes (median overall survival: 14 months). However, the patients in this cohort also exhibited certain unique features: high frequencies of thrombocytopenia (n = 15, 88%) and monocytosis in peripheral blood (n = 15, 88%) and decreased megakaryocytes (n = 11, 65%). In summary, the pericentric inv(3)s are often subtle/cryptic by chromosomal analysis. A reflex FISH analysis for MECOM-R is recommended in myeloid neoplasms showing −7/del(7q). MECOM rearrangement (MECOM-R) resulting from 3q26.2 aberrations is often associated with myeloid neoplasms and inferior prognosis in affected patients. Uncommonly, certain 3q26.2/MECOM-R can be subtle/cryptic and consequently overlooked by karyotyping. We identified 17 acute myeloid leukemia (AML) patients (male/female: 13/4 with a median age of 67 years, range 42 to 85 years) with a pericentric inv(3) leading to MECOM-R, with breakpoints at 3p23 (n = 11), 3p25 (n = 3), 3p21 (n = 2) and 3p13 (n = 1) on 3p and 3q26.2 on 3q. These pericentric inv(3)s were overlooked by karyotyping initially in 16 of 17 cases and later detected by metaphase FISH analysis. Similar to the patients with classic/paracentric inv(3)(q21q26.2), patients with pericentric inv(3) exhibited frequent cytopenia, morphological dysplasia (especially megakaryocytes), −7/del(7q), frequent NRAS (n = 6), RUNX1 (n = 5) and FLT-3 (n = 4) mutations and dismal outcomes (median overall survival: 14 months). However, patients with pericentric inv(3) more frequently had AML with thrombocytopenia (n = 15, 88%), relative monocytosis in peripheral blood (n = 15, 88%), decreased megakaryocytes (n = 11, 65%), and lower SF3B1 mutation. We conclude that AML with pericentric inv(3) shares some similarities with AML associated with classic/paracentric inv(3)/GATA2::MECOM but also shows certain unique features. Pericentric inv(3)s are often subtle/cryptic by chromosomal analysis. A reflex FISH analysis for MECOM-R is recommended in myeloid neoplasms showing −7/del(7q).
DOI: 10.1111/j.1365-2141.2011.08918.x
发表时间: 2012-01-01
影响因子: 6.5
作者:
Duhoux, Francois P.;Ameye, Genevieve;Poirel, Helene A.
通讯作者: Poirel, Helene A.
DOI: 10.1016/j.cell.2014.02.019
发表时间: 2014-04-10
期刊: CELL
影响因子: 64.5
作者:
Groeschel, Stefan;Sanders, Mathijs A.;Delwel, Ruud
通讯作者: Delwel, Ruud
DOI: 10.3892/ol.2014.1784
发表时间: 2014-03-01
期刊: ONCOLOGY LETTERS
影响因子: 2.9
作者:
Al Achkar, Walid;Aljapawe, Abdulmunim;Wafa, Abdulsamad
通讯作者: Wafa, Abdulsamad
DOI: 10.1016/0165-4608(94)90030-2
发表时间: 1994-05-01
影响因子: --
作者:
HEIMANN, P;VAMOS, E;SARIBAN, E
通讯作者: SARIBAN, E
DOI: 10.1097/hs9.0000000000000471
发表时间: 2020-10
期刊: HemaSphere
影响因子: 6.6
作者:
D'Angiò M;Fazio G;Grioni A;Palamini S;Sala S;Galbiati M;Biondi A;Balduzzi A;Rizzari C;Cazzaniga G
通讯作者: Cazzaniga G